MEDICAMEN BIOTECH
Back to Balance Sheet
|
MEDICAMEN BIOTECH Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-3.17 Cr | ₹-2.83 Cr | ₹-2.52 Cr | ₹-1.88 Cr | ₹-0.50 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of MEDICAMEN BIOTECH ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2026 | ₹-3.17 Cr |
| Mar2025 | ₹-2.83 Cr |
| Mar2024 | ₹-2.52 Cr |
| Mar2023 | ₹-1.88 Cr |
| Mar2022 | ₹-0.50 Cr |
How is Deferred Tax Assets / Liabilities of MEDICAMEN BIOTECH Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-3.17 Cr | Negative | |
| Mar2025 | ₹-2.83 Cr | Negative | |
| Mar2024 | ₹-2.52 Cr | Negative | |
| Mar2023 | ₹-1.88 Cr | Negative | |
| Mar2022 | ₹-0.50 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of MEDICAMEN BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MEDICAMEN BIOTECH | ₹375.0 Cr | -11.4% | -20.6% | -15.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,204.0 Cr | -1% | -5.5% | 5.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹240,780.0 Cr | -2.6% | -3.9% | 38.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,828.0 Cr | -1.7% | -10.2% | 30.5% | Stock Analytics | |
| CIPLA | ₹109,305.0 Cr | 0.9% | -3.2% | -15.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,759.0 Cr | -0.6% | 1% | -0.1% | Stock Analytics | |
MEDICAMEN BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MEDICAMEN BIOTECH | -11.4% |
-20.6% |
-15.2% |
| SENSEX | -1.5% |
-1.2% |
-11.8% |
You may also like the below Video Courses